American Century Companies’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-35,867
Closed -$139K 2917
2023
Q3
$139K Sell
35,867
-4,712
-12% -$25.3K ﹤0.01% 2666
2023
Q2
$242K Buy
40,579
+22,114
+120% +$127K ﹤0.01% 2468
2023
Q1
$57.4K Buy
18,465
+7,734
+72% +$30.9K ﹤0.01% 2611
2022
Q4
$42.4K Hold
10,731
﹤0.01% 2547
2022
Q3
$64K Buy
+10,731
New +$77.4K ﹤0.01% 2388

Other funds holding SANA

American Century Companies's SANA Position: Q4 2023 in Review

American Century Companies sold out of Sana Biotechnology (SANA) in Q4 2023, closing a stake of 35,867 shares — an estimated $139K sold.

American Century Companies first reported a position in SANA in Q3 2022 and held it in 5 quarters. The position peaked at $242K in Q2 2023. 132 funds tracked by Wall St. Rank hold SANA as of Q4 2023.

  • American Century Companies reported no remaining Sana Biotechnology position as of Q4 2023 after selling out during the quarter.
  • American Century Companies sold 35,867 Sana Biotechnology shares in Q4 2023, an estimated $139K.
  • American Century Companies first reported a position in Sana Biotechnology in Q3 2022 and held it in 5 quarters.
  • American Century Companies's Sana Biotechnology position peaked at $242K in Q2 2023.
  • 132 funds tracked by Wall St. Rank held Sana Biotechnology as of Q4 2023.

Based on American Century Companies's 13F filing for Q4 2023, filed 13 Feb 2024.